A carregar...
5PSQ-031 Pneumocystis carinii pneumonia prevention in lung transplantation: is atovaquone effective?
BACKGROUND: Pneumocystis carinii pneumonia (PCP) is an uncommon severe complication in immunocompromised patients. There is only one marketed treatment to prevent PCP: trimethoprime-sulfamethoxazole (TMP-SMZ). Due to side-effects (mainly neutropaenia), TMP-SMZ is sometimes replaced by off-label drug...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535716/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.385 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|